Medtronic Change in Accounts Receivable 2010-2025 | MDT
- Medtronic change in accounts receivable for the quarter ending April 30, 2025 was $-0.433B, a 10.74% increase year-over-year.
- Medtronic change in accounts receivable for the twelve months ending April 30, 2025 was $-0.688B, a 42.15% increase year-over-year.
- Medtronic annual change in accounts receivable for 2025 was $-0.433B, a 10.74% increase from 2024.
- Medtronic annual change in accounts receivable for 2024 was $-0.391B, a 32.12% decline from 2023.
- Medtronic annual change in accounts receivable for 2023 was $-0.576B, a 20.75% increase from 2022.
Medtronic Annual Change in Accounts Receivable (Millions of US $) |
|
---|---|
2025 | $-433 |
2024 | $-391 |
2023 | $-576 |
2022 | $-477 |
2021 | $-761 |
2020 | $1,291 |
2019 | $-581 |
2018 | $-275 |
2017 | $-75 |
2016 | $-435 |
2015 | $-413 |
2014 | $-70 |
2013 | $1 |
2012 | $-252 |
2011 | $-342 |
2010 | $-271 |
2009 | $108 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $119.233B | $33.537B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $229.305B | 26.89 |
Boston Scientific (BSX) | United States | $152.872B | 36.46 |
Stryker (SYK) | United States | $146.007B | 29.72 |
EssilorLuxottica (ESLOY) | France | $145.127B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $48.282B | 0.00 |
Haleon (HLN) | United Kingdom | $43.313B | 24.74 |
ResMed (RMD) | United States | $41.712B | 29.83 |
Agilent Technologies (A) | United States | $33.861B | 22.07 |
GE HealthCare Technologies (GEHC) | United States | $33.512B | 15.75 |
Terumo (TRUMY) | Japan | $27.642B | 32.75 |
Koninklijke Philips (PHG) | Netherlands | $26.451B | 17.50 |
Insulet (PODD) | United States | $22.615B | 75.77 |
Zimmer Biomet Holdings (ZBH) | United States | $20.354B | 12.96 |
Smith & Nephew SNATS (SNN) | United Kingdom | $15.855B | 0.00 |
Baxter (BAX) | United States | $12.419B | 9.60 |
Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
Demant (WILYY) | Denmark | $8.121B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.731B | 28.40 |
Lantheus Holdings (LNTH) | United States | $3.684B | 9.96 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.430B | 24.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.198B | 14.19 |
Perrigo (PRGO) | Ireland | $3.123B | 7.80 |
ICU Medical (ICUI) | United States | $2.986B | 20.33 |
Haemonetics (HAE) | United States | $2.589B | 11.56 |
LeMaitre Vascular (LMAT) | United States | $2.171B | 46.56 |
Curaleaf Holdings (CURLF) | Canada | $1.782B | 0.00 |
AtriCure (ATRC) | United States | $1.762B | 0.00 |
QuidelOrtho (QDEL) | United States | $1.761B | 11.08 |
Green Thumb Industries (GTBIF) | United States | $1.601B | 68.73 |
AdaptHealth (AHCO) | United States | $1.283B | 18.24 |
Phibro Animal Health (PAHC) | United States | $1.243B | 15.89 |
Acuren (TIC) | United States | $1.190B | 0.00 |
Neogen (NEOG) | United States | $1.179B | 18.72 |
BioLife Solutions (BLFS) | United States | $1.166B | 2434.00 |
Tilray Brands (TLRY) | Canada | $1.134B | 0.00 |
Valneva SE (VALN) | France | $0.981B | 0.00 |
InMode (INMD) | Israel | $0.907B | 8.39 |
Kestra Medical Technologies (KMTS) | United States | $0.824B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.665B | 0.00 |
Surmodics (SRDX) | United States | $0.536B | 0.00 |
ZimVie (ZIMV) | United States | $0.532B | 20.49 |
SNDL (SNDL) | Canada | $0.531B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.482B | 0.00 |
CeriBell (CBLL) | United States | $0.451B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.451B | 15.53 |
Owens & Minor (OMI) | United States | $0.439B | 3.89 |
Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
Evolus (EOLS) | United States | $0.435B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.364B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.331B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
Canopy Growth (CGC) | Canada | $0.312B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.287B | 0.00 |
Omeros (OMER) | United States | $0.272B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.254B | 0.00 |
Brainsway (BWAY) | Israel | $0.245B | 49.92 |
Cerus (CERS) | United States | $0.238B | 0.00 |
Vireo Growth (VREOF) | United States | $0.234B | 0.00 |
High Tide (HITI) | Canada | $0.216B | 0.00 |
Quanterix (QTRX) | United States | $0.212B | 0.00 |
Exagen (XGN) | United States | $0.209B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
Organigram Global (OGI) | Canada | $0.192B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.178B | 14.83 |
TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
Biote (BTMD) | United States | $0.144B | 4.79 |
Jushi Holdings (JUSHF) | United States | $0.116B | 0.00 |
MacroGenics (MGNX) | United States | $0.100B | 0.00 |
Jin Medical (ZJYL) | China | $0.096B | 0.00 |
Fonar (FONR) | United States | $0.094B | 12.08 |
Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
Apyx Medical (APYX) | United States | $0.082B | 0.00 |
Safety Shot (SHOT) | United States | $0.078B | 0.00 |
Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
Agape ATP (ATPC) | $0.063B | 0.00 | |
ImmuCell (ICCC) | United States | $0.055B | 32.12 |
Veru (VERU) | United States | $0.053B | 0.00 |
Zynex (ZYXI) | United States | $0.046B | 0.00 |
Nephros (NEPH) | United States | $0.045B | 35.42 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 14.05 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.029B | 0.00 |
Senestech (SNES) | United States | $0.024B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InterCure (INCR) | Israel | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |